GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Nanopharmaceutics Inc (OTCPK:TGRP) » Definitions » Inventories, Other

Nanopharmaceutics (Nanopharmaceutics) Inventories, Other : $0.12 Mil (As of Sep. 2018)


View and export this data going back to 2016. Start your Free Trial

What is Nanopharmaceutics Inventories, Other?

Other inventories including goods for resale, stocks in transit, consignment stocks, etc. Nanopharmaceutics's other inventories for the quarter that ended in Sep. 2018 was $0.12 Mil.

Nanopharmaceutics's quarterly other inventories declined from Mar. 2018 ($0.16 Mil) to Jun. 2018 ($0.15 Mil) and declined from Jun. 2018 ($0.15 Mil) to Sep. 2018 ($0.12 Mil).


Nanopharmaceutics Inventories, Other Historical Data

The historical data trend for Nanopharmaceutics's Inventories, Other can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Nanopharmaceutics Inventories, Other Chart

Nanopharmaceutics Annual Data
Trend Dec15 Dec16 Dec17
Inventories, Other
- - -

Nanopharmaceutics Quarterly Data
Mar16 Jun16 Sep16 Dec16 Mar17 Jun17 Sep17 Dec17 Mar18 Jun18 Sep18
Inventories, Other Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only - - 0.16 0.15 0.12

Nanopharmaceutics Inventories, Other Calculation

Other inventories including goods for resale, stocks in transit, consignment stocks, etc.


Nanopharmaceutics (Nanopharmaceutics) Business Description

Traded in Other Exchanges
N/A
Address
14120 NW 126 Terrace, Alachua, FL, USA, 32615
Nanopharmaceutics Inc is a clinical-stage specialty pharmaceutical company. It is engaged in developing oral, topical, and injectable products for cancer, central nervous system (CNS) disorders, and infectious diseases. The company's pipeline products include Triapine, Ammonium Tetrathiomolybdate, and Aza-TdC targeting cancer; NanoBUP, PRX-3140, NP-18-2, and NP-18-3 targeting CNS; and Ramoplanin and NanoDOX.